Description: This session is about the methods of projecting long-run stock returns using inflation rates from bond yield curves with incremental returns for risk taking based on historical data and the relationship between concurrent, expected and unexpected inflation rates and the rates of return on common stocks and U.S. government bonds and notes. From Record of Society of Actuaries Vol. 5, No. 4.

Description: Presented at May 2002 Spring Meeting. Discusses the status of the second phase of the AAA C-3 Risk project. This project is leading to an updated NAIC filing requirement and is a step toward fair value. The specific focus is on equity risk and bond funds in the distribution tails. Products covered include variable life and annuities.

Description: The presenters describe the process payers and employers can use to evaluate emerging medical device technologies, recent or pending FDA submissions for prescription drugs and experimental treatments that impact patient care, resource utilization and health care expenditures. Learn the process of identifying and selecting impactful treatments (Horizon Scanning) and quantifying the financial cost of new technologies before they arrive in the market. These workflows can be leveraged by actuaries, healthcare economists, clinicians and pharmacists from a payer (Commercial and Medicare) and employer perspective for self-funded plans. Walk through sample models that illustrate how costs for emerging technologies and treatments can be modeled.

Description: Presented at October 1996 Annual Meeting. This session presents and discusses the NAIC's model bill for risk-based capital as it relates to health insurance.

Description: This presentation from Session 85 of the SOA June 2005 New Orleans Health/Pension Spring Meeting discusses recent developments in the area of capital planning, what are appropriate capital levels, and how health actuaries should be involved in it. From the Record of the Society of Actuaries, Vol. 31, No. 2.

Description: Risk management techniques such as stress testing and setting capital targets are fairly well established for life insurers; however, the implementation of these techniques can vary considerably. A fundamental question is how to manage multiple valuation perspectives, and the list of possibilities keeps growing. Companies can potentially consider some or all of the following: U.S. reporting measures (Stat, GAAP), internal measures (EV, VNB, economic capital), international reporting measures (IFRS), rating agency models or other developing standards (ICS, NAIC group capital). This session will begin with a quick overview of the defining characteristics of different valuation frameworks. We will then provide more focused and practical considerations for managing risk and capital under different frameworks, using specific examples to highlight key trade offs.

Description: Presented at September 1995 Valuation Actuary Symposium. Discusses the Health Organization Risk-Based Capital formula.

Description: Presented at May 1985 Spring Meeting. Discusses: Target surplus formulas for specific product lines, Projecting product line surplus needs, How cost of capital is charged to product lines, Criteria to use in allocating capital to or withdrawing capital from specific product lines, Differing techniques appropriate for stock and mutual companies, Differing techniques appropriate for the United States and Canada, How capital allocation relates to regulatory requirements, How capital allocation relates to competition in other industries.

Description: Presented at September 1995 Valuation Actuary Symposium. Discusses surplus management, including RBC, the capital management process and techniques, allocations of capital, raising capital, and rating agencies.

Description: This panel will discuss the current status of NAIC activities with respect to risk-based capital RBC. The potential impact on financial reporting with respect to health products, specifically, indemnity, HMO, disability, and nontraditional products will also be discussed. From the Record of the Society of Actuaries, Vol.21, No. 4a.